FluoGuide Strengthens Leadership to Advance Clinical Program and Regulatory Approval Strategy

KØBENHAVN, DK / ACCESS Newswire / November 5, 2025 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, announces changes to both its corporate management and Board of Directors to …
Jetzt den vollständigen Artikel lesen